x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The MM+M Podcast

The MM+M Podcast

MM+M editors Jameson Fleming, Jack O"Brien, Heerea Rikhraj and Lecia Bushak speak with people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes released each week.

business marketing

All Episodes

00:41:22

Reaching audiences while protecting health data....

The MM+M Podcast ·

2025/10/15

Following a very successful 2025 MM+M Awards, we bring you a special two-part episode.This week, reporter Heerea Rikhraj brings us an insightful conversation with Blueprint Audiences co-founder Jeremy Mittler about how to reach target audiences while still protecting health data.In lieu of our regular Trends segments, we bring you some additional audio from the MM+M Awards.This includes Titanium Award honoree Jamie-Lynn Sigler’s keynote address and several interviews with winners on the red

en

00:18:09

Live from the red carpet at the 2025 MM+M Awards

The MM+M Podcast ·

2025/10/10

Broadcasting from the floor of the Cipriani Wall Street, managing editor Jack O’Brien and editor-at-large Steve Madden spoke with executives from agencies and pharma brands celebrating medical marketing’s biggest night.Listen to what medical marketing leaders told MM+M about the top industry trends before 2025 MM+M Awards got underway. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of

en

00:37:58

Previewing the 2025 MM+M Awards with Jury Chair...

The MM+M Podcast ·

2025/10/08

Thursday is the year’s biggest night in medical marketing.Ahead of the 2025 MM+M Awards, Jury Chair Meghan Rivera discusses the top pharma advertising work nominated for honors.Without spoiling the results, Rivera provides industry leaders with a sense of what differentiated some of the health submissions from the rest of the field and earned accolades.Then during the Trends segment, members of the editorial team take stock of the AI tools recently rolled out by medical marketing agencies and

en

00:32:25

How healthcare companies partner with private equity

The MM+M Podcast ·

2025/10/07

In this new series, MM+M explores the growing presence of private equity in the healthcare world. Host Heerea Rikhraj connects with Tom Donnelly of Supreme Group and Liz Kanter of Pivot Design to explore how private equity is transforming healthcare marketing. They share how their partnership with Trinity Hunt formed, how it enabled growth and how it helped them access resources while keeping creativity and culture at the forefront. The conversation also touches on common perceptions of private

en

00:36:54

Defending neurodiversity in the face of Trump’s...

The MM+M Podcast ·

2025/09/30

It’s been just over a week since the Trump administration very publicly claimed that Tylenol usage is linked to an increased rate of autism.Based on dubious evidence, the White House asserted that acetaminophen – the active ingredient in Tylenol – is what’s behind the “current autism epidemic.”For all of the bluster and upheaval that arose from the communications coming out of 1600 Pennsylvania Avenue, there are real lessons to be learned for health brands and medical marketers on a professional

en

00:45:04

Publicis Health Media invests for the future and the...

The MM+M Podcast ·

2025/09/24

Medical marketing is faced with gale-force winds of uncertainty, so we’re going to spend most of this week’s episode focused on the industry’s future but in two distinct ways.For our feature interview, we’re joined by recurring guest Andrea Palmer, the CEO of Publicis Health Media, as well as Brad Liebow, who recently jumped from Spark Foundry to become PHM’s first chief investment officer.The pair explain why the position was established, how it is designed to further differentiate PHM from other

en

00:44:51

What happens when you stop taking GLP-1s? Plus, the...

The MM+M Podcast ·

2025/09/17

If there are two topics medical marketers can’t get enough of, it’s GLP-1s and the ongoing crackdown on DTC pharma ads. This week’s episode of the MM+M Podcast delves into what happens when patients stop taking GLP-1s as well as how the first week of the Trump administration’s enhanced enforcement of restrictions on DTC pharma ads has gone.To start the episode, reporter Heerea Rikhraj brings us a conversation with Dr. Innocent Clement, CEO and founder of CIBA Health, about what happens after people

en

00:20:05

Empathy decoded: What drives healthcare decisions?, a...

The MM+M Podcast ·

2025/09/10

In this episode, we explore the story behind the Empathy Engine — Syneos Health Communications’ groundbreaking consumer data hub that's transforming the way healthcare brands connect with people. Built at the intersection of behavioral science and emotional insight, the Empathy Engine reveals the "why" behind health decisions. Hear from the minds behind the Engine and learn how it’s helping marketers deliver stories that matter and drive positive change — before audiences even know they need to hear

en

00:32:15

The truth behind Incyte’s HS Truths educational push

The MM+M Podcast ·

2025/09/10

Hidradenitis suppurativa (HS) is, by all accounts, a painful disease.An estimated 3 million Americans live with HS, which is most commonly identified by flare ups as well as painful and unflattering lumps under the skin.Over the past few years, drugmakers have launched campaigns and marketing efforts to bring greater attention and understanding to the disease.Recently, Incyte launched HS Truths – an educational campaign to shine a spotlight on the physical symptoms of the disease as well as the

en

00:16:46

Mental health warrior Jon Nelson unveils NeuroLivd

The MM+M Podcast ·

2025/09/09

Managing editor Jack O’Brien talks with medical marketer turned mental health warrior Jon Nelson and neuroscientist Dr. Rachel Wurzman about their consulting firm NeuroLivd.The organization is dedicated to infusing lived experience perspectives into the mental health, wellness and neurological space – fueled by their passion and substance as well as rooted in their own deep lived experience within these conditions. Music - Mark Buergler - On The Run (Instrumental), Triple Scoop Music Step into the

en

00:15:55

A diagnostics company, NFLPA team to raise awareness...

The MM+M Podcast ·

2025/09/05

Alexion recently launched the second film in its Rare Connections series, Rare Connections in gMG.Managing editor Jack O’Brien talks with Lucid Diagnostics' chief technology and compliance officer Dr. Brian deGuzman about the company’s nationwide initiative to provide education and testing for esophageal precancer.He explains how the NFLPA factors into the effort, which launched in Cincinnati, and how it is expanding across the country to address the heightened risk these athletes have for

en

00:17:26

HCP marketing in an omnichannel world, a podcast...

The MM+M Podcast ·

2025/09/03

Explore the latest trends in HCP content consumption and how pharma marketers can adapt their strategies to reach their target audience effectively with The Trade Desk's senior director of business development Lindsay Reardon and Swoop's VP of client success Kevin Elwell. They will share research insights into how HCPs engage online, highlighting the growing importance of CTV and audio channels, how a data-driven approach can break down silos between HCP and DTC campaigns and how to elevate patient

en

00:41:37

The 2025 NFL season kicks off. Medical marketers and...

The MM+M Podcast ·

2025/09/03

Are you ready for some football?The 2025 NFL season kicks off this week with the defending champion Philadelphia Eagles hosting the Dallas Cowboys on Thursday night.The highest linear TV ratings are usually delivered by live sports broadcasts and no entity is a more reliable generator for eyeballs than the NFL.It should then come as no surprise that drugmakers want to intensify their relationship with the league.Take, for example, Novartis was named the first-ever corporate pharmaceutical partner of

en

00:41:00

Ready Player Type 1: A video game designed for...

The MM+M Podcast ·

2025/08/27

Video games are big fun and even bigger money.The International Trade Administration estimated that the value of the global video game industry in 2023 was $184 billion – with more than 3.2 billion gamers worldwide. Recognizing this new trend in media consumption and content engagement, medical marketers have been trying to break through in the gaming world.Few have had as much success as Level Ex – which develops video games for physicians.Almost a year ago, Level Ex was bought by Relevate Health,

en

00:39:47

Meet the biopharma CEO who’s bullish on...

The MM+M Podcast ·

2025/08/20

Just over two years ago, the FDA issued its first draft guidance on clinical trials with psychedelic drugs. Now, HHS has hired a dedicated psychedelics advisor. This week, Reunion Neuroscience reported a mid-stage success with its short-acting psychedelic drug in postpartum depression.At a moment of increasing momentum – both in terms of research, funding and commercial promise – behind psychedelics, it’s worth checking in with one of the leaders in the space: Cybin, a clinical-stage biopharma.In

en

00:12:09

AstraZeneca's Alexion doubles down on rare disease...

The MM+M Podcast ·

2025/08/14

Alexion recently launched the second film in its Rare Connections series, Rare Connections in gMG.Managing editor Jack O’Brien talks with Christophe Hotermans, Alexion’s head of global medical affairs, about the multimedia effort to raise the profile of gMG.For this week’s MM+M Fast Break, Hotermans discusses the drugmaker’s latest rare disease-focused film.Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full

en

00:32:03

MM+M summer intern Lola Offenback's exit interview

The MM+M Podcast ·

2025/08/13

Every year at Haymarket Media, we bring in a cohort of about 30 interns for eight weeks over the summer to learn the ropes across our business media, medical communications and internal operations units.For us here at MM+M, our intern exit interview gets recorded and sent out into the world. Over the past few weeks on the podcast, you’ve heard from our summer intern, Lola Offenback.In addition to contributing to our discussions of the top news stories in the Trends segment, she has led insightful

en

00:13:20

Currax’s human-centric campaign sets an example for...

The MM+M Podcast ·

2025/08/08

MM+M summer intern Lola Offenback sits down with Derrick Gastineau to discuss Currax Pharmaceuticals’ latest human-centered campaign, Real Patients, Real Results.Gastineau emphasized the importance of authentic patient voices in marketing. He explains the selection process for patient stories, Currax’s unique position in the weight loss market and how they measure the campaign's success through engagement. He also delves into the channels used for consumer outreach, future storytelling strategies

en

00:16:31

Ways medical marketers can bridge the gap for HIV...

The MM+M Podcast ·

2025/08/07

Reporter Heerea Rikhraj sits down with Dr. Alftan Dyson to discuss the high rates of HIV amongst Black communities. Dr. Dyson discusses treatments like PrEP, which the Centers of Disease Control and Prevention estimates that around 2.2 million people in the U.S. need, up from previous estimates of 1.2 million. Dr. Dyson delves into the initiatives ViiV Healthcare is working on to tackle this issue, and touches on how marketers can get involved. Step into the future of health media at the MM+M Media

en

00:45:24

The art of marketing health insurers and the end of...

The MM+M Podcast ·

2025/08/06

It’s nearly impossible to discuss the private health insurance landscape in America without referencing the killing of UnitedHealthcare CEO Brian Thompson last December.The shooting unleashed a wave of antipathy directed at insurers and brought deep-seeded, longstanding grievances against these for-profit health entities to the fore.In the intervening months, UnitedHealth Group and the broader insurer class have suffered significant damage not only to their respective bottom lines, but also their

en

657 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Nomad Capitalist Audio Experience

Nomad Capitalist

Supply Shock

Blockworks

RadioBorsa - La tua guida controcorrente per investire bene nella Borsa e nella Vita

SoldiExpert SCF